Scilex Holding Co, trading under the ticker symbol SCLX, has emerged as a significant player in the biopharmaceutical industry. The company’s focus on developing and commercializing non-opioid pain management products has garnered attention from investors and healthcare professionals alike. In this article, we will delve into the strengths, weaknesses, opportunities,